Clincosm LogoSign in Get a demo

recurrent cervical cancer

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer Trial in Mobile (Cabozantinib 40 MG oral once a day,

Terminated
  • Cervical Cancer
  • +3 more
  • Cabozantinib 40 MG oral once a day
  • Pembrolizumab 200 mg IV every 3 weeks
  • Mobile, Alabama
    University of South Alabama Mitchell Cancer Institute
Jun 3, 2022

Recurrent Cervical Cancer Trial in Guangzhou (anti-PD-1+Albumin-Bound Paclitaxel)

Active, not recruiting
  • Recurrent Cervical Cancer
  • anti-PD-1+Albumin-Bound Paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 26, 2022

Stage IVB Cervical Cancer, Recurrent Cervical Cancer, Persistent Cervical Cancer Trial in Guangzhou (Camrelizumab, Apatinib,

Recruiting
  • Stage IVB Cervical Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 25, 2021

Genetic Mutation in Recurrent Cervical Cancer

Unknown status
  • Recurrent Cervical Cancer
  • +8 more
  • Multi-gene panel testing
  • Beijing, Beijing, China
    Lei Li
Dec 18, 2019

Recurrent Cervical Cancer Trial in Guangzhou (Cryosurgery, NK immunotherapy)

Completed
  • Recurrent Cervical Cancer
  • Cryosurgery
  • NK immunotherapy
  • Guangzhou, Guangdong, China
    Fuda cancer institute of Fuda cancer hospital
Sep 10, 2019

Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer Trial in Philadelphia (bevacizumab, laboratory biomarker analysis)

Completed
Has Results
  • Cervical Squamous Cell Carcinoma
  • Recurrent Cervical Cancer
  • bevacizumab
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Anxiety Disorder, Depression, Fatigue Trial in Columbus (other, procedure, behavioral)

Completed
  • Anxiety Disorder
  • +19 more
  • questionnaire administration
  • +5 more
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 8, 2015

Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma Trial in Kingston (sunitinib

Completed
Has Results
  • Cervical Adenocarcinoma
  • +4 more
  • sunitinib malate
  • Kingston, Ontario, Canada
    National Cancer Institute of Canada Clinical Trials Group
Feb 4, 2015

Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Estrogen Receptor-negative Breast Cancer Trial in

Completed
  • Advanced Adult Primary Liver Cancer
  • +87 more
  • Charlottesville, Virginia
    University of Virginia
Sep 27, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer Trial in Philadelphia (erlotinib HCl, laboratory biomarker analysis)

Completed
  • Cervical Squamous Cell Carcinoma
  • Recurrent Cervical Cancer
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jan 16, 2013

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,

Completed
  • Adult Anaplastic Astrocytoma
  • +85 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013

Cervical Intraepithelial Neoplasia Grade 1, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade

Withdrawn
  • Cervical Intraepithelial Neoplasia Grade 1
  • +24 more
  • colposcopy
  • +2 more
  • (no location specified)
Jun 8, 2012